Ortiz A, et al. Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERAEDTA. Nephrol Dial Transplant 2021; 36:87–94. doi: 10.1093/ndt/gfaa314

• PubMed
Ortiz A, Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERAEDTA. Nephrol Dial Transplant 2021; 36:87–94. doi: 10.1093/ndt/gfaa314 )| false
• Search Google Scholar
• Export Citation

Zúñiga J, et al. SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP. [Article in Spanish.] Nefrología [published online ahead of print January 28, 2021]. doi: 10.1016/j.nefro.2020.12.008; https://www.sciencedirect.com/science/article/pii/S021169952100014X?via%3Dihub

• PubMed
Zúñiga J, SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP. [Article in Spanish.] Nefrología [published online ahead of print January 28, 2021]. doi: 10.1016/j.nefro.2020.12.008; https://www.sciencedirect.com/science/article/pii/S021169952100014X?via%3Dihub )| false
• Search Google Scholar
• Export Citation

Rincón A, et al. The keys to control a COVID-19 outbreak in a haemodialysis unit. Clin Kidney J 2020; 13:542–549. doi: 10.1093/CKJ/SFAA119

• PubMed
Rincón A, The keys to control a COVID-19 outbreak in a haemodialysis unit. Clin Kidney J 2020; 13:542–549. doi: 10.1093/CKJ/SFAA119 )| false
• Search Google Scholar
• Export Citation

Hsu CM, et al. COVID-19 among US dialysis patients: Risk factors and outcomes from a national dialysis provider. Am J Kidney Dis 2021; 77:748-756.e1. doi: 10.1053/j.ajkd.2021.01.003

• PubMed
Hsu CM, COVID-19 among US dialysis patients: Risk factors and outcomes from a national dialysis provider. Am J Kidney Dis 2021; 77:748-756.e1. doi: 10.1053/j.ajkd.2021.01.003 )| false
• Search Google Scholar
• Export Citation

Dagan N, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 2021; 384:1412–1423. doi: 10.1056/nejmoa2101765

• PubMed
Dagan N, BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 2021; 384:1412–1423. doi: 10.1056/nejmoa2101765 )| false
• Search Google Scholar
• Export Citation

Lim WH, et al. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int 2007; 72:1138–1148. doi: 10.1038/sj.ki.5002425

• PubMed
Lim WH, Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int 2007; 72:1138–1148. doi: 10.1038/sj.ki.5002425 )| false
• Search Google Scholar
• Export Citation

Eleftheriadis T, et al. Infections in hemodialysis: A concise review. Part II: Blood transmitted viral infections. Hippokratia 2011; 15:120–126. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209673/

• PubMed
Eleftheriadis T, Infections in hemodialysis: A concise review. Part II: Blood transmitted viral infections. Hippokratia 2011; 15:120–126. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209673/ )| false
• Search Google Scholar
• Export Citation

Grupper A, et al. Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol [published online ahead of print April 6, 2021]. doi: 10.2215/cjn.03500321; https://cjasn.asnjournals.org/content/early/2021/04/05/CJN.03500321

• PubMed
Grupper A, Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol [published online ahead of print April 6, 2021]. doi: 10.2215/cjn.03500321; https://cjasn.asnjournals.org/content/early/2021/04/05/CJN.03500321 )| false
• Search Google Scholar
• Export Citation

Simon B, et al. Hemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls. medRxiv [pre-print published online ahead of print March 26, 2021]. doi: https://doi.org/10.1101/2021.03.26.21254259; https://www.medrxiv.org/content/10.1101/2021.03.26.21254259v1

• PubMed
Simon B, Hemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls. medRxiv [pre-print published online ahead of print March 26, 2021]. doi: https://doi.org/10.1101/2021.03.26.21254259; https://www.medrxiv.org/content/10.1101/2021.03.26.21254259v1 )| false
• Search Google Scholar
• Export Citation

Torreggiani M, et al. Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: The war is far from being won. Kidney Int [published online ahead of print April 20, 2021]. doi: 10.1016/j.kint.2021.04.010; https://www.kidney-international.org/article/S0085-2538(21)00395-1/fulltext

• PubMed
Torreggiani M, Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: The war is far from being won. Kidney Int [published online ahead of print April 20, 2021]. doi: 10.1016/j.kint.2021.04.010; https://www.kidney-international.org/article/S0085-2538(21)00395-1/fulltext )| false
• Search Google Scholar
• Export Citation

Yanay NB, et al. Experience with SARS-COV-2 BNT162b2 mRNA vaccine in dialysis patients. Kidney Int [published online ahead of print April 20, 2021]. doi: 10.1016/j.kint.2021.04.006; https://www.kidney-international.org/article/S0085-2538(21)00390-2/full-text

• PubMed
Yanay NB, Experience with SARS-COV-2 BNT162b2 mRNA vaccine in dialysis patients. Kidney Int [published online ahead of print April 20, 2021]. doi: 10.1016/j.kint.2021.04.006; https://www.kidney-international.org/article/S0085-2538(21)00390-2/full-text )| false
• Search Google Scholar
• Export Citation

Frantzen L, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in a hemodialysis cohort. Nephrol Dial Transplant [published online ahead of print April 24, 2021]. doi: 10.1093/ndt/gfab165; https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfab165/6251363

• PubMed
Frantzen L, Efficacy of the BNT162b2 mRNA COVID-19 vaccine in a hemodialysis cohort. Nephrol Dial Transplant [published online ahead of print April 24, 2021]. doi: 10.1093/ndt/gfab165; https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfab165/6251363 )| false
• Search Google Scholar
• Export Citation

Agur T, et al. Antibody response to mRNA SARSCoV-2 vaccine among dialysis patients—a prospective cohort study. Nephrol Dial Transplant [published online ahead of print April 11, 2021]. doi: 10.1093/ndt/gfab155; https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfab155/6220326

• PubMed
Agur T, Antibody response to mRNA SARSCoV-2 vaccine among dialysis patients—a prospective cohort study. Nephrol Dial Transplant [published online ahead of print April 11, 2021]. doi: 10.1093/ndt/gfab155; https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfab155/6220326 )| false
• Search Google Scholar
• Export Citation

Lacson Jr E, et al. Immunogenicity of SARSCoV-2 vaccine in dialysis. medRxiv [preprint published online ahead of print April 13, 2021]. doi: 10.1101/2021.04.08.21254779; https://www.medrxiv.org/content/10.1101/2021.04.08.21254779v1

• PubMed
Lacson Jr E, Immunogenicity of SARSCoV-2 vaccine in dialysis. medRxiv [preprint published online ahead of print April 13, 2021]. doi: 10.1101/2021.04.08.21254779; https://www.medrxiv.org/content/10.1101/2021.04.08.21254779v1 )| false
• Search Google Scholar
• Export Citation